ストックスクリーナーアプリを入手
0.5826
8.97%
-0.0574
アフターアワーズ：
.56
-0.0226
-3.88%
前日終値:
$0.64
開ける：
$0.62
24時間の取引高:
253.53K
Relative Volume:
0.69
時価総額：
$27.61M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.83%
1か月 パフォーマンス:
-61.16%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.55
$0.62
1週間の範囲:
$0.55
$0.6708
52週間の値動き範囲:
$0.52
$2.10
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
名前
Aspire Biopharma Holdings Inc
セクター
電話
561-704-8527
住所
1200 BROADWAY, FLOOR 3, NEW YORK
ASBP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.5826 | 27.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Aspire Biopharma Holdings Inc (ASBP) 最新ニュース
There is no way Aspire Biopharma Holdings Inc (ASBP) can keep these numbers up - SETE News
Sector Update: Health Care -March 20, 2025 at 01:41 pm EDT - MarketScreener
Aspire Biopharma Says Glatt Air Produces First Batch of Oral Mucosal Form of Aspirin -March 20, 2025 at 10:11 am EDT - Marketscreener.com
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin - standard-journal.com
Aspire Biopharma advances patent applications for drug delivery tech By Investing.com - Investing.com Australia
Aspire Biopharma advances patent applications for drug delivery tech - Investing.com India
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform - ACCESS Newswire
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation - The Kingston Whig-Standard
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement - WICZ
Dykema Advises PowerUp Acquisition Corp. in Aspire Biopharma’s Nasdaq Listing - Dykema
Aspire Biopharma advances to phase 1 clinical trial for aspirin product - Investing.com India
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin - Corsicana Daily Sun
PowerUp Acquisition Corp. Approves Merger with Aspire Biopharma - MSN
Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga India
Aspire Biopharma Strengthens Financial Position with Debentures - TipRanks
Stock market news: Aspire Biopharma Holdings -51.46%, bluebird bio -39.20% among biggest losers during midday trading - Business Upturn
Stock market news: MicroAlgo skyrocketed by 480.87% whereas Mobile-health Network plunged by 42.65% during midday trading - Business Upturn
POWERUP ACQUISITION CORP. Submission of Matters to a Vote of Security Holders (form 8-K/A) - Marketscreener.com
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement - WICZ
Aspire Biopharma Goes Public with PowerUp Acquisition - TipRanks
ASBPAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq - ACCESS Newswire
PowerUp Acquisition Completes Combination; Aspire Biopharma Gains Nasdaq Listing - Marketscreener.com
Aspire Biopharma begins trading on Nasdaq post-merger By Investing.com - Investing.com Nigeria
PowerUp Acquisition stock soars to all-time high of $15.15 - Investing.com India
Aspire Biopharma and PowerUp set merger terms, eye Nasdaq listing - Investing.com India
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp. - StockTitan
Aspire Biopharma Holdings Inc (ASBP) 財務データ
Aspire Biopharma Holdings Inc (ASBP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):